1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2021;71(3):209-249.
2. Kurman RJ, Carcangiu ML, Herrington CS, et al. Tumours of the uterine corpus. WHO classification of tumours of female reproductive organs. 4thed. Lyon, France: IARCH; 2014. p. 121-54.
3. Shiozaki T, Miwa M, Sakuma T, et al. Correlation between pre-operative and final histological diagnosis on endometrial cancer. Int J Gynecol Cancer.2019;29(5):886-889.
4. Clarke BA, Gilks CB. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol. 2010;63(5):410-415.
5. Tanaka K, Kobayashi Y, Sugiyama J, et al. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer. Int J Clin Oncol. 2017;22(3):533-540.
6. Piotto MASB, Focchi GRA, Marques RM, et al. Assessment of preoperative endometrial histopathological sampling as a predictor of final surgical pathology in endometrial cancer. Rev Bras Ginecol Obstet. 2020;42(10):642-648
7. Franchi M, Ghezzi F, Riva C, et al. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78(4):232-240.
8. Petersen RW, Quinlivan JA, Casper GR, et al. Endometrial adenocarcinoma-presenting pathology is a poor guide to surgical management. Australia NZ J Obstetrics Gynaecol. 2000;40(2):191-194.
9. Wang X, Huang Z, Di W, et al. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients. Arch Gynecol Obstet. 2005;272(2):136-141.
10. Francis JA, Weir MM, Ettler HC, et al. Should preoperative pathology be used to select patients for surgical staging in endometrial cancer? Int J Gynecol Cancer. 2009;19(3):380-384.
11. Ben-Shachar I, Pavelka J, Cohn DE, et al.Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol. 2005; 105(3):487-493.
12. Cohn DE, Huh WK, Fowler JM, et al. Cost-effectiveness analysis of strategiesfor the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol. 2007;109(6):1388-1395.
13. Eltabbakh GH, Shamonki J, Mount SL. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.Gynecol Oncol. 2005; 99(2):309-312.
14. Akış S, Kabaca C, Keleş E, et al. Tumor diameter as a predictor of lymph node involvement in endometrioid type endometrial adenocarcinomas. J Obstet Gynaecol Res. 2021;47(11):3968-3978.
15. Doghri R, Chaabouni S, Houcine Y, et al. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer. Mol Clin Oncol. 2018;9(1):87-91.
16. Yan B, Liang X, Zhao T, et al. Is the standard deviation of the apparent diffusion coefficient a potential tool for the preoperative prediction of tumor grade in endometrial cancer? Acta Radiol. 2020;61(12):1724-1732.
17. Chung HH, Kang SB, Cho JY, et al. Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol. 2007;104(3):654-659.
18. Keles E, Akış S, Özyürek Ş, et al. How specific are CA-125 levels in ruling out extra-uterine extension of endometrial serous papillary cancer? JGON. 2022;19(2):1255-1259.
19. Asami Y, Hiranuma K, Takayanagi D, et al. Predictive model for thepreoperative assessment and prognostic modeling of lymph nodemetastasis in endometrial cancer. Sci Rep. 2022;12(1):19004.
20. Case AS, Rocconi RP, Straughn JM Jr, et al. A prospective blindedevaluation of the accuracy of frozen section for the surgical managementof endometrial cancer. Obstet Gynecol. 2006;108(6):1375-1379.
21. Sanjuán A, Cobo T, Pahisa J, et al. Preoperative and intraoperativeassessment of myometrial invasion and histologic grade in endometrialcancer: role of magnetic resonance imaging and frozen section. Int JGynecol Cancer. 2006;16(1):385-390.